Venom-Neutralising Antibody

Venom-Neutralising Antibody mind map
  Recent News
    Synthetic Human Antibody Developed
    Neutralizes Snake Neurotoxins
      Across Different Species
      Various Geographies
    Antibody Name
      2554_01_D11
    Researchers
      Technical University of Denmark
      Indian Institute of Science
      Scripps Research Institute
    Published Studies
      Nature Communications
      Science Translational Medicine
  When
    Study Published
      February 2023
  Why
    Combat Snakebites
    Reduce Mortality
    Universal Antivenom Development
  What
    Antibody Characteristics
      Extensive Cross-Reactivity
      Partial Neutralization
        Black Mamba Venom
      Targets Neurotoxins
    Application
      Future Envenoming Therapies
      Broadly Neutralizing Antibodies
    Adapted Approach
      Previously Used for HIV, COVID-19
  Where
    Geographical Impact
      Worldwide Relevance
    High-Risk Regions
      India
      Sub-Saharan Africa
  Who
    Involved Parties
      Andreas Hougaard Laustsen-Kiel
      Senji Laxme
      Kartik Sunagar
    Institutions
      Technical University of Denmark
      Indian Institute of Science
      Scripps Research Institute
  How
    Research Methodology
      Screened for Antibodies
      Tested on Animal Models
      Yeast Cell Surface Display Technique
    Toxin Target
      Three-Finger Toxin (3FTx)
      Conserved Disulphide Core
  Significance
    Improved Efficacy
      15 Times More Effective
      Broad Protection
    Reduces Need for Animal Antibodies
    Potential in Other Therapies
      Cancer
      Other Toxins
  Challenges
    Incomplete Neutralization
      Certain Venoms
    Clinical Trials Required
    Production Scalability
  Way Forward
    Further Testing
      More Snake Species
    Clinical Trials
    Potential Universal Antivenom Creation

Venom-neutralising antibodies represent a groundbreaking advancement in the field of antivenom research. Scientists have developed a synthetic human antibody, 2554_01_D11, capable of neutralizing snake neurotoxins from various species globally. This development, led by researchers from the Technical University of Denmark, Indian Institute of Science, and Scripps Research Institute, was published in Nature Communications and Science Translational Medicine. The antibody, adapted from methods used in HIV and COVID-19 research, targets a conserved region in the toxin, showing potential for broad protection against different snake venoms. This innovation is a significant step towards creating a universal antivenom, offering hope for more effective treatments against snakebites, a major health concern in regions like India and sub-Saharan Africa.

Related Posts

If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.

Responses

🖍️ Highlight
HomeCoursesPlansAccount